amphetamine and lsp4-2022

amphetamine has been researched along with lsp4-2022 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acher, F; Gruca, P; Lasoń-Tyburkiewicz, M; Marciniak, M; Papp, M; Pilc, A; Wierońska, JM; Woźniak, M1
Acher, F; Cieślik, P; Conn, PJ; Kusek, M; Pilc, A; Rook, JM; Tantawy, MN; Tokarski, K; Wierońska, JM; Woźniak, M1

Other Studies

2 other study(ies) available for amphetamine and lsp4-2022

ArticleYear
Involvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022.
    Current neuropharmacology, 2016, Volume: 14, Issue:5

    Topics: Amphetamine; Animals; Antipsychotic Agents; Cyclopentanes; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Agonists; GABA Agents; Male; Mice, Knockout; Motor Activity; Phosphinic Acids; Pyrimidines; Receptors, GABA-B; Receptors, Metabotropic Glutamate; Recognition, Psychology; Schizophrenia; Social Behavior

2016
Mutual activation of glutamatergic mGlu
    Psychopharmacology, 2018, Volume: 235, Issue:10

    Topics: Amphetamine; Animals; Antipsychotic Agents; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Male; Mice; Motor Activity; Phosphinic Acids; Receptor, Muscarinic M4; Receptors, Metabotropic Glutamate; Rodentia; Schizophrenia

2018